Weed (BUDZ) Share-based Compensation (2010 - 2025)
Weed's (BUDZ) quarterly Share-based Compensation came in at $75000.0 in Q4 2025, up 400.0% quarter-over-quarter from $15000.0 in Q1 2025.
Weed (BUDZ) Share-based Compensation (2010 - 2025) Analysis & Trends
Weed's Share-based Compensation history runs 11 years deep, the most recent figure standing at $75000.0 for Q4 2025.
- On a quarterly basis, Share-based Compensation changed N/A year-over-year to $75000.0 in Q4 2025; TTM through Mar 2026 was $75000.0, a 158.62% increase from a year earlier, with the FY2025 full-year figure at $90000.0, up 542.86% from the prior year.
- Share-based Compensation advanced to $75000.0 in Q4 2025 per BUDZ's latest filing, from $15000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.0 million in Q2 2021 and bottomed at -$45000.0 in Q3 2023.
- The 5-year median for Share-based Compensation is $75000.0 (2025), against an average of $187363.3.
- Biggest YoY gain for Share-based Compensation was 300.0% in 2023; the steepest drop was 154.02% in 2023.
- Year by year, Share-based Compensation stood at $216000.0 in 2021, then tumbled by 89.58% to $22500.0 in 2022, then surged by 300.0% to $90000.0 in 2023, then plunged by 84.44% to $14000.0 in 2024, then soared by 435.71% to $75000.0 in 2025.
- Per Business Quant, the three latest BUDZ Share-based Compensation figures stand at $75000.0 (Q4 2025), $15000.0 (Q1 2025), and $14000.0 (Q2 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Weed | 3.72 Mn | 3.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 75,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Mar 31, 2025 | 15,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Sep 30, 2023 | -45,000.00 |
| Sep 30, 2023 | -45,000.00 |
| Jun 30, 2023 | 22,500.00 |
| Jun 30, 2023 | 22,500.00 |
| Mar 31, 2023 | 22,500.00 |
| Mar 31, 2023 | 22,500.00 |
| Dec 31, 2022 | 22,500.00 |
| Dec 31, 2022 | 22,500.00 |
| Sep 30, 2022 | 83,300.00 |
| Sep 30, 2022 | 83,300.00 |
| Jun 30, 2022 | 193,600.00 |
| Jun 30, 2022 | 193,600.00 |